Cardio Diagnostics Holdings, Inc. Increase (Decrease) in Prepaid Expenses, Other
Cardio Diagnostics Holdings, Inc. (CDIO) reported Increase (Decrease) in Prepaid Expenses, Other of -$876.07 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2023-11-13
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2023-09-30 was -$317.04K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2023-06-30 was -$220.92K, a 346.99% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2023-03-31 was -$338.11K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-12-31 was $651.25K.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expenses, other for fiscal 2022 was $690.82K, a 2127.81% increase from fiscal 2021.
- Cardio Diagnostics Holdings, Inc. increase (decrease) in prepaid expenses, other for fiscal 2021 was $31.01K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$317.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$537.96K derived: sum of 2 quarters · filed 2023-11-13 | -$876.07K 10-Q · filed 2023-11-13 | -$224.81K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -$220.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$559.03K 10-Q · filed 2023-08-14 | $92.23K derived: sum of 3 quarters · filed 2023-08-14 | $62.71K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | -$338.11K 10-Q · filed 2023-05-15 | $313.15K derived: sum of 2 quarters · filed 2023-05-15 | $283.63K derived: sum of 3 quarters · filed 2023-11-13 | $373.07K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $651.25K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $621.73K derived: sum of 2 quarters · filed 2023-11-13 | $711.18K derived: sum of 3 quarters · filed 2023-11-13 | $690.82K 10-K · filed 2023-03-31 |
| 2022-09-30 | -$29.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $59.93K derived: sum of 2 quarters · filed 2023-11-13 | $39.57K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $89.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $69.09K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$20.36K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $31.01K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |